News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Onyia Jude
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,198 shares
@ $107.3696, valued at
$343.4k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| Onyia Jude (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.57, valued at
$276.5k
|
|
| 02/27/2023 |
4
| Onyia Jude (Director) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $6.92, valued at
$304.5k
|
|
| 02/27/2023 |
3
| Onyia Jude (Director) has filed a Form 3 on Voyager Therapeutics, Inc. |
| 02/08/2023 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 4,508 shares
@ $102.2995, valued at
$461.2k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,331 shares
@ $121.9048, valued at
$284.2k
|
|
| 02/02/2022 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 6,464 options
@ $79.02, valued at
$510.8k
Granted 950 restricted stock units
@ $0 |
|
| 12/01/2021 |
4
| Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 120,169 options
@ $84.74, valued at
$10.2M
Granted 17,702 restricted stock units
@ $0 |
|
| 12/01/2021 |
3
| Onyia Jude (Chief Scientific Officer) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC |
|
|